Artificial Intelligence Unlocks Diabetic Edema Secrets
  • View Times: 57
  • |
  • Release Date: 2025-01-06
  • diabetic macular edema
  • artificial intelligence
  • biomarker
  • spectral domain OCT
  • outcomes
  • subretinal fluid
  • intraretinal fluid
  • hyperreflective retinal foci
  • external limiting membrane
  • ellipsoid zone
Chapter
00:12
Introduction
00:36
Materials and Methods
01:58
Results
02:42
Discussion
03:56
Conclusion
Video Introduction

This video is adapted from 10.3390/jcm12062134

Artificial intelligence (AI) and deep learning (DL)-based systems have gained wide interest in macular disorders, including diabetic macular edema (DME). This paper aims to validate an AI algorithm for identifying and quantifying different major optical coherence tomography (OCT) biomarkers in DME eyes by comparing the algorithm to human expert manual examination. Intraretinal (IRF) and subretinal fluid (SRF) detection and volumes, external limiting-membrane (ELM) and ellipsoid zone (EZ) integrity, and hyperreflective retina foci (HRF) quantification were analyzed. Three-hundred three DME eyes were included. The mean central subfield thickness was 386.5 ± 130.2 µm. IRF was present in all eyes and confirmed by AI software. The agreement (kappa value) (95% confidence interval) for SRF presence and ELM and EZ interruption were 0.831 (0.738–0.924), 0.934 (0.886–0.982), and 0.936 (0.894–0.977), respectively. The accuracy of the automatic quantification of IRF, SRF, ELM, and EZ ranged between 94.7% and 95.7%, while accuracy of quality parameters ranged between 99.0% (OCT layer segmentation) and 100.0% (fovea centering). The Intraclass Correlation Coefficient between clinical and automated HRF count was excellent (0.97). This AI algorithm provides a reliable and reproducible assessment of the most relevant OCT biomarkers in DME. It may allow clinicians to routinely identify and quantify these parameters, offering an objective way of diagnosing and following DME eyes.

Full Transcript
Video Production Service